• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Prometheus Biosciences Inc (NQ: RXDX )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Jun 15, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 199.92 (9)
    Ask (Size) 199.99 (7)
    Prev. Close 199.92
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 41,700,063
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Shares of Exscientia Jumped on Wednesday
    The company may be riding the wave of an AI healthcare boom. 
    Via The Motley Fool
    From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
    Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as... 
    Via Benzinga

    Performance

    More News

    Read More
    Why Shares of Ventyx Biosciences Rose Monday
    Via The Motley Fool
    Is Merck Stock a Top Buy Right Now?
    Via The Motley Fool
    The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
    Via Investor's Business Daily
    3 Innovative Growth Stocks to Buy for Next-Gen Profits
    Via InvestorPlace
    RXDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Prometheus Biosciences, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    3 Undervalued Pharma Stocks to Buy for High Total Returns
    Via InvestorPlace
    FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
    Via Benzinga
    Horizon Tumbles — Taking Seagen, Prometheus With It — On Reports FTC Could Block Its Amgen Takeover
    Via Investor's Business Daily
    Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
    Via Benzinga
    Prometheus Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Progress
    From Prometheus Biosciences
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth’s Inc. (Nasdaq – RUTH), Magenta Therapeutics, Inc. (Nasdaq – MGTA), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April
    Via Benzinga
    Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?
    Via Investor's Business Daily
    Merck Makes a Bold Move That Could Transform Its Business
    Via The Motley Fool
    3 Biotechs That Might Get Bought Out in 2023
    Via The Motley Fool
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE – UNVR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    This Supercharged Dividend King Stock Might Soon Run Out of Steam
    Via The Motley Fool
    PROMETHEUS BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review
    Via Investor's Business Daily
    Why Prometheus Biosciences Stock Is Skyrocketing This Week
    Via The Motley Fool
    Why This Nasdaq Stock Caught Fire This Week
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.